ストックスクリーナーアプリを入手
234.31
0.59%
-1.40
アフターアワーズ：
235.00
0.69
+0.29%
前日終値:
$235.71
開ける：
$238.93
24時間の取引高:
910.79K
Relative Volume:
1.08
時価総額：
$15.04B
収益：
$13.84B
当期純損益:
$1.10B
株価収益率:
22.49
EPS:
10.4185
ネットキャッシュフロー:
$1.49B
1週間 パフォーマンス:
+5.32%
1か月 パフォーマンス:
+21.93%
6か月 パフォーマンス:
+111.07%
1年 パフォーマンス:
+64.07%
1日の値動き範囲:
$230.99
$239.64
1週間の範囲:
$220.50
$239.64
52週間の値動き範囲:
$101.00
$239.64
Davita Inc Stock (DVA) Company Profile
Compare DVA vs HCA, THC, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
234.31 | 15.13B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
423.11 | 92.52B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
208.82 | 17.76B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
24.20 | 12.68B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
110.72 | 10.61B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
The DaVita In-Center HemodialysisA core service tailored to U.S. kidney patients - AD HOC NEWS
DaVita Stock Rockets 13% With 10-Day Winning Streak - Trefis
DaVita Inc. outlines growth path as kidney care demand rises - AD HOC NEWS
DaVita Inc and its role in the US dialysis market. Long-term fundamentals and business model in focu - AD HOC NEWS
DaVita Inc. focuses on kidney care as long-term demand supports the business - AD HOC NEWS
The DaVita In-Center Hemodialysis Programsteady lifeline for US kidney patients - AD HOC NEWS
Insiders At DaVita Sold US$33m In Stock, Alluding To Potential Weakness - Moomoo
DaVita (DVA) Is Up 8.2% After AI Kidney Care Push And Buyback Boosts NarrativeWhat's Changed - simplywall.st
DaVita Inc. focuses on core dialysis services as investors weigh long term care demand - AD HOC NEWS
DaVita (DVA) Q1 2026 Earnings Call Transcript - Fortune
Price to book forward of DaVita Inc. – NYSE:DVA - TradingView
DaVita (DVA) Stock Could Be 19% Overvalued Despite Strong Q1 Results - Yahoo Finance
Is DaVita Inc. (DVA) A Good Stock To Buy Now? - Yahoo Finance
DaVita Inc. focuses on core dialysis business as investors watch US healthcare trends - AD HOC NEWS
DaVita (DVA) Expands Integrated Kidney Care With AI Tools For Dialysis Care - Yahoo Finance
DaVita Inc (DVA) Stock Up 3.0% but GF Value Says Overvalued -- G - GuruFocus
DaVita Inc. focuses on core dialysis services as investors weigh long-term growth - AD HOC NEWS
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Best Growth Stocks to Buy for July 2nd - Yahoo! Finance Canada
Federal Judge Narrows Ex-DaVita Worker's Retaliation Suit - Law360
DaVita Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
DaVita Inc. focuses on core dialysis business as investors weigh long-term demand - AD HOC NEWS
The DaVita PD Advocate mobile appDaVita Inc. leans on at-home kidney care support - AD HOC NEWS
Novi dialysis center set to reopen after investigation in patient death, other hospitalizations - WXYZ Channel 7
DaVita Inc.’s Stock Price Soars to $222.48, Marking an Impressive 1.27% Uptick - Smartkarma
Berkshire Manager Weschler May Be Having A Good Year Due to DaVita, Sirius Holdings - Barron's
Warren Buffett’s Berkshire Hathaway Has Held DaVita Inc. (DVA) Since 2011 - Insider Monkey
DaVita Stock Benefits From Strengthening Kidney Care Delivery - Yahoo Finance
DaVita's Novi dialysis center to reopen Thursday, saying equipment reviews found no issues - CBS News
DaVita stock benefits from expanding community-based kidney care - MSN
DaVita Inc.(NYSE: DVA) added to Russell Midcap Value Benchmark - marketscreener.com
DaVita Inc.(NYSE: DVA) added to Russell 1000 Value Benchmark - marketscreener.com
DaVita Inc.(NYSE: DVA) added to Russell 3000 Value Benchmark - marketscreener.com
DaVita clear strategy focus, shares anchored in US healthcare - AD HOC NEWS
Price to book forward of DaVita Inc. – HAM:TRL - TradingView
What are Wall Street analysts' target price for DaVita stock? - MSN
ScheduleHub from DaVita Inc.AI helps tame dialysis scheduling - AD HOC NEWS
DaVita expands specialized care beyond acute settings through IKC - MSN
Enterprise value to revenue forward of DaVita Inc. – HAM:TRL - TradingView
DaVita with a cautious strategy focus, shares on the NYSE in a defensive sector - AD HOC NEWS
How Investors May Respond To DaVita (DVA) Upgraded Outlook And Expanding Value-Based Kidney Care Initiatives - Sahm
DaVita Inc. Actuals & Estimates (NYSE:DVA) - TradingView
Why the Market Dipped But DaVita HealthCare (DVA) Gained Today - Yahoo Finance
DaVita Dialysis Center investigation being handled by State of Michigan - CBS News
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
DaVita Dialysis Center investigation now being handled by State of Michigan - CBS News
State Officials Take Over Investigation of Death of DaVita Dialysis Patient - WJR-AM
State Offcials Takes Over Investigation Into Death of DaVita Dialysis Patient - WJR-AM
DaVita expands comprehensive kidney care through dialysis services - MSN
S&P 500 Futures Drop in Premarket Trading; ON Semiconductor, DaVita Lag - Barron's
DaVita clears US reimbursement hurdle, shares react to muted Medicare proposal - AD HOC NEWS
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
2.50%
大文字化:
|
ボリューム (24 時間):